版本:
中国

BRIEF-Bristol-Myers enters collaboration to identify predictive biomarkers across multiple tumor types, immunotherapy agents

March 30 Bristol-Myers Squibb Co:

* Bristol-Myers Squibb enters collaboration to leverage Foundation Medicine's molecular information platform to identify predictive biomarkers across multiple tumor types and immunotherapy agents Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐